Showing 1 - 2 results of 2 for search 'Rodryg Ramlau', query time: 0.01s Refine Results
  1. 1
    Safety of unconventional antibody-drug conjugate L-DOS47 in a phase I/II monotherapy study targeting advanced NSCLC

    Safety of unconventional antibody-drug conjugate L-DOS47 in a phase I/II monotherapy study targeting advanced NSCLC by Rodryg Ramlau, Dariusz M. Kowalski, Aleksandra Szczęsna, Cezary Szczylik, Young Ou, Martin Köbel, Gabrielle M. Siegers, Kim J. Gaspar, Brenda Lee, Kazimierz Roszkowski-Sliz

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib study

    Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-l... by Glenwood Goss, Tudor Ciuleanu, Rodryg Ramlau, Daniel J. Renouf, Quincy Chu, Ewa Kalinka, Piotr Sawrycki, Jonathan Bramson, Brad H. Nelson, Rafael Crabbé, Eric LaCasse, Bryan Lo, Daniela A. Sahlender, Philippa Crompton, Franck Brichory, Luke Piggott, Michael Schenker, Rosalyn Juergens

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: